Xu, W.; Cong, Z.; Duan, Q.; Wang, Q.; Su, S.; Wang, R.; Lu, L.; Xue, J.; Jiang, S.
A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile. Pharmaceuticals 2022, 15, 424.
https://doi.org/10.3390/ph15040424
AMA Style
Xu W, Cong Z, Duan Q, Wang Q, Su S, Wang R, Lu L, Xue J, Jiang S.
A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile. Pharmaceuticals. 2022; 15(4):424.
https://doi.org/10.3390/ph15040424
Chicago/Turabian Style
Xu, Wei, Zhe Cong, Qianyu Duan, Qian Wang, Shan Su, Rui Wang, Lu Lu, Jing Xue, and Shibo Jiang.
2022. "A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile" Pharmaceuticals 15, no. 4: 424.
https://doi.org/10.3390/ph15040424
APA Style
Xu, W., Cong, Z., Duan, Q., Wang, Q., Su, S., Wang, R., Lu, L., Xue, J., & Jiang, S.
(2022). A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile. Pharmaceuticals, 15(4), 424.
https://doi.org/10.3390/ph15040424